Sign In
Sign In
Forgot Password
Or
Cancel
Sign In
Enter Reason Of Report:
Report Now!
USFDA issues warning letter to Intas Pharma for Sanand plant
Home
Healthcare
USFDA issues warning letter to Intas Pharma for Sanand plant
Healthcare
halaalcommerce.com
No Comments
6 August 2023
The USFDA inspected the manufacturing facility from November 22 to December 2, 2022. A warning letter is issued when the US health regulator finds that a manufacturer has significantly violated its regulations
#healthcare
Previous
There is no widget. You should add your widgets into
Default
sidebar area on
Appearance => Widgets
of your dashboard.
